Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s Actis Equity Firm Adds To Paras Ownership, Hires New CEO

This article was originally published in PharmAsia News

Executive Summary

A private equity firm increased its control of Paras Pharmaceuticals and hired a new CEO to manage the firm. Actis now holds 60 percent of the shares in Paras, a private company, after a deal with a member of the founding Patel family, which retains 30 percent. The CEO, who was not identified, is expected to take over in two months. Principals in the two firms would not comment. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts